首页> 外文期刊>Quarterly Journal of Medicine >The Edinburgh City Hospital cohort: analysis of enrolment, progression and mortality by baseline covariates
【24h】

The Edinburgh City Hospital cohort: analysis of enrolment, progression and mortality by baseline covariates

机译:爱丁堡市立医院队列:通过基线协变量分析入学,进展和死亡率

获取原文
获取原文并翻译 | 示例
       

摘要

We describe baseline characteristics, enrolment, progression and mortality of the Edinburgh City Hospital HIV cohort. There were 431 men and 191 (31%) women; 439 (71%) infected via injection drug use (IDU); 92 (15%) via homosexual intercourse; 84 (13%) via heterosexual intercourse and 7 from blood products. Median annual rate of CD4 cell loss was 49 (90% range: 15-146); Both homosexual men and patients aged > 40 years at enrolment lost CD4 cells significantly more quickly. In multifactorial analysis controlled for baseline CO4 count and IgA, there was no gender effect, but young patients ( < 25 years) progressed significantly more slowly to AIDS (RR 0.4, p = 0.00). Homosexual men progressed significantly more quickly than IDUs, with adjusted relative risks (RR) of 2.9 (p = 0.00), 2.5 (p = 0.01) and 1.5 (p = 0.1) for progression to CDC stage IV, AIDS and death, respectively. The three-year survival rate post-AIDS was 25% (SE 4.3) and there was no gender effect on survival. There was, however, an age effect whereby individuals diagnosed with AIDS in their 40s or later showed poorer survival (RR 1.9, p = 0.04). Zido-vudine treatment after art AIDS diagnosis significantly lengthened post-AIDS survival (RR 0.5, p = 0.08).
机译:我们描述了爱丁堡市医院HIV队列的基线特征,入组,进展和死亡率。男431例,女191例,占31%。 439人(71%)通过注射吸毒(IDU)感染; 92(15%)通过同性恋性交; 84次(13%)通过异性性交,而7次来自血液制品。 CD4细胞流失的中位数年率是49(90%范围:15-146);同性恋男性和年龄大于40岁的患者入选CD4细胞的速度明显更快。在控制基线CO4计数和IgA的多因素分析中,没有性别影响,但是年轻患者(<25岁)进展为艾滋病的速度明显较慢(RR 0.4,p = 0.00)。同性恋男子的发展速度明显快于注射吸毒者,进入CDC IV期,艾滋病和死亡的调整后相对风险(RR)分别为2.9(p = 0.00),2.5(p = 0.01)和1.5(p = 0.1)。艾滋病后的三年生存率为25%(SE 4.3),并且性别对生存没有影响。但是,有一种年龄效应,即在40岁或40岁以后被诊断出患有AIDS的个体存活率较低(RR 1.9,p = 0.04)。艾滋病诊断后的齐多-伏丁治疗显着延长了艾滋病后的生存期(RR 0.5,p = 0.08)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号